(Q41676632)

6 October 2017

title

Diltiazem retards the metabolism of oral prednisone with effects on T-cell markers (English)

1 reference

6 October 2017

Imani S

1

1 reference

6 October 2017

Jusko WJ

series ordinal

2

1 reference

6 October 2017

Steiner R

series ordinal

3

1 reference

6 October 2017

publication date

1 May 1999

1 reference

Pediatric Transplantation

6 October 2017

published in

1 reference

6 October 2017

volume

3

1 reference

6 October 2017

issue

2

1 reference

6 October 2017

page(s)

126-130

1 reference

Pharmacokinetic determinants of cyclosporine and prednisone in renal transplant patients

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

LAGRAN program for area and moments in pharmacokinetic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

Hormonal and metabolic effects of calcium channel antagonists in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

Diltiazem modulates monokine production in human mixed lymphocyte culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

Methylprednisolone dosage effects on peripheral lymphocyte subpopulations and eicosanoid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

Fifteen years of operation of a high-performance liquid chromatographic assay for prednisolone, cortisol and prednisone in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

7 January 2021

Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

7 January 2021

Pharmacokinetic interaction between cyclosporin and diltiazem

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

7 January 2021

Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

7 January 2021

Adrenal suppression and steroid supplementation in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

7 January 2021

Diltiazem in renal allograft recipients receiving cyclosporine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

7 January 2021

Withdrawal of steroid immunosuppression in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

7 January 2021

Clinical observations of metabolic changes occurring in renal transplant recipients receiving ketoconazole

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

7 January 2021

The effect of cyclosporine on the pharmacokinetics of prednisolone in renal transplant patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00027.X

7 January 2021

10.1034/J.1399-3046.1999.00027.X

Identifiers

DOI

1 reference

release_ztsh5zjgqjgjrcqfhduvwlv2ym

6 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ztsh5zjgqjgjrcqfhduvwlv2ym

24 November 2022

mapped directly with Wikidata item

1 reference